Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
ASTH — Astrana Health, Inc.
NASDAQ
FULL STOCK PAGE →

Q2 2026 Earnings Call Summary

AUG 6, 2026
REVENUE
$972.5M +0.8%
NET MARGIN
2.0% +0.5 PTS
EPS
$0.40 +33.3%
FREE CASH FLOW
$92.9M +45.1%

No summary has been written for this call yet.